Historical award
Eitr Biologics, Inc.
This record is historical buying context, not open work.
How current is this award history?
Fiscal year 2025: data through (14 days old).
Fiscal year 2026: data through (14 days old).
Official release availability details
Fiscal year 2025: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
Fiscal year 2026: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
- Current award value
- $33,059,642.43
- Potential award value
- $317,552,135.13
- Total obligated to date
- $33,059,642.43
Source date: Nov 9, 2026
Recorded work
THE DEVELOPMENT OF A MULTIMODAL ANTIBODY PLATFORM TO EXTEND THE WINDOW OF IMMUNOTHERAPEUTIC INTERVENTION. THE OVERALL OBJECTIVE OF THE WORK OUTLINED IN THIS CONTRACT IS TO CRITICALLY EVALUATE THE UTILITY OF THE VHH AS A PLATFORM MCM TECHNOLOGY FOR VI
Award activity
- Obligations in covered fiscal years
- $6,445,465.43
- Transactions in covered fiscal years
- 4
Award value and obligated funds describe different amounts. Review the official record for the full transaction history.
Record identifier
CONT_AWD_75A50123C00060_7505_-NONE-_-NONE-